{"id":"https://openalex.org/W1898697707","doi":"https://doi.org/10.1111/bjh.13766","title":"Excellent outcomes and lack of prognostic impact of cell of origin for localized diffuse large B-cell lymphoma in the rituximab era","display_name":"Excellent outcomes and lack of prognostic impact of cell of origin for localized diffuse large B-cell lymphoma in the rituximab era","alternate_titles":[],"publication_year":2015,"publication_date":"2015-10-12","ids":{"openalex":"https://openalex.org/W1898697707","doi":"https://doi.org/10.1111/bjh.13766","mag":"1898697707","pmid":"https://pubmed.ncbi.nlm.nih.gov/26456939","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/4715539"},"language":"en","primary_location":{"id":"doi:10.1111/bjh.13766","doi":"https://doi.org/10.1111/bjh.13766","is_oa":false,"landing_page_url":"https://doi.org/10.1111/bjh.13766","pdf_url":null,"source":{"id":"https://openalex.org/S153015021","display_name":"British Journal of Haematology","issn_l":"0007-1048","issn":["0007-1048","1365-2141"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Haematology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1898697707"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC4715539/","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5089206024","display_name":"Anita Ashok Kumar","orcid":"https://orcid.org/0000-0002-1381-5810","observed_orcids":["https://orcid.org/0000-0002-1381-5810"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Anita Kumar","raw_affiliation_strings":["Lymphoma Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lymphoma Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088179815","display_name":"Matthew Alexander Lunning","orcid":"https://orcid.org/0000-0002-2761-7612","observed_orcids":["https://orcid.org/0000-0002-2761-7612"]},"institutions":[{"id":"https://openalex.org/I59130452","display_name":"University of Nebraska Medical Center","ror":"https://ror.org/00thqtb16","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I59130452"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Matthew A. Lunning","raw_affiliation_strings":["University of Nebraska, Medical Center, Omaha, NE, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Nebraska, Medical Center, Omaha, NE, USA","institution_ids":["https://openalex.org/I59130452"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100373989","display_name":"Zhigang Zhang","orcid":"https://orcid.org/0000-0002-1556-7945","observed_orcids":["https://orcid.org/0000-0002-1556-7945"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Zhigang Zhang","raw_affiliation_strings":["Biostatistics and Epidemiology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biostatistics and Epidemiology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074374512","display_name":"Jocelyn C. Migliacci","orcid":"https://orcid.org/0000-0002-5882-0728","observed_orcids":["https://orcid.org/0000-0002-5882-0728"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jocelyn C. Migliacci","raw_affiliation_strings":["Lymphoma Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lymphoma Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001102192","display_name":"Craig H. Moskowitz","orcid":"https://orcid.org/0000-0002-9189-3152","observed_orcids":["https://orcid.org/0000-0002-9189-3152"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Craig H. Moskowitz","raw_affiliation_strings":["Lymphoma Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lymphoma Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5061964017","display_name":"Andrew David Zelenetz","orcid":"https://orcid.org/0000-0003-1403-6883","observed_orcids":["https://orcid.org/0000-0003-1403-6883"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Andrew D. Zelenetz","raw_affiliation_strings":["Lymphoma Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lymphoma Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA","institution_ids":["https://openalex.org/I1334819555"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5089206024"],"corresponding_institution_ids":["https://openalex.org/I1334819555"],"apc_list":{"value":5190,"currency":"USD","value_usd":5190},"apc_paid":null,"fwci":1.7357,"has_fulltext":false,"cited_by_count":42,"citation_normalized_percentile":{"value":0.84665428,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":99},"biblio":{"volume":"171","issue":"5","first_page":"776","last_page":"783"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12212","display_name":"CNS Lymphoma Diagnosis and Treatment","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10685","display_name":"Viral-associated cancers and disorders","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/diffuse-large-b-cell-lymphoma","display_name":"diffuse large B-cell lymphoma","score":0.925000011920929},{"id":"https://openalex.org/keywords/localized-lymphoma","display_name":"localized lymphoma","score":0.6480000019073486},{"id":"https://openalex.org/keywords/cell-of-origin","display_name":"cell of origin","score":0.9589999914169312},{"id":"https://openalex.org/keywords/non-gcb-dlbcl","display_name":"non-GCB DLBCL","score":0.7689999938011169},{"id":"https://openalex.org/keywords/r-chop","display_name":"R-CHOP","score":0.9570000171661377},{"id":"https://openalex.org/keywords/involved-field-radiotherapy","display_name":"involved-field radiotherapy","score":0.9459999799728394},{"id":"https://openalex.org/keywords/short-course-chemotherapy","display_name":"short-course chemotherapy","score":0.6010000109672546},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.7549999952316284},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.9990000128746033},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.8410000205039978},{"id":"https://openalex.org/keywords/hans-algorithm","display_name":"Hans algorithm","score":0.578000009059906},{"id":"https://openalex.org/keywords/international-prognostic-index","display_name":"International Prognostic Index","score":0.9039999842643738}],"concepts":[{"id":"https://openalex.org/C2780653079","wikidata":"https://www.wikidata.org/wiki/Q412323","display_name":"Rituximab","level":3,"score":0.8580677509307861},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7738291621208191},{"id":"https://openalex.org/C2779429289","wikidata":"https://www.wikidata.org/wiki/Q408977","display_name":"Vincristine","level":4,"score":0.7578613758087158},{"id":"https://openalex.org/C2778476033","wikidata":"https://www.wikidata.org/wiki/Q1667625","display_name":"International Prognostic Index","level":4,"score":0.735359251499176},{"id":"https://openalex.org/C2778559949","wikidata":"https://www.wikidata.org/wiki/Q2626074","display_name":"Diffuse large B-cell lymphoma","level":3,"score":0.6929415464401245},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6776950359344482},{"id":"https://openalex.org/C2779725641","wikidata":"https://www.wikidata.org/wiki/Q1076228","display_name":"CHOP","level":3,"score":0.6689754724502563},{"id":"https://openalex.org/C146357865","wikidata":"https://www.wikidata.org/wiki/Q1123245","display_name":"Stage (stratigraphy)","level":2,"score":0.5795609951019287},{"id":"https://openalex.org/C2776755627","wikidata":"https://www.wikidata.org/wiki/Q408524","display_name":"Cyclophosphamide","level":3,"score":0.5605740547180176},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.5263342261314392},{"id":"https://openalex.org/C2779714933","wikidata":"https://www.wikidata.org/wiki/Q289306","display_name":"B symptoms","level":3,"score":0.5223256945610046},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5004067420959473},{"id":"https://openalex.org/C2780739268","wikidata":"https://www.wikidata.org/wiki/Q2112244","display_name":"Progression-free survival","level":3,"score":0.4414237439632416},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.39188310503959656},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.25271546840667725},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0},{"id":"https://openalex.org/C151730666","wikidata":"https://www.wikidata.org/wiki/Q7205","display_name":"Paleontology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000069283","descriptor_name":"Rituximab","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D003131","descriptor_name":"Combined Modality Therapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003520","descriptor_name":"Cyclophosphamide","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D004317","descriptor_name":"Doxorubicin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011241","descriptor_name":"Prednisone","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014750","descriptor_name":"Vincristine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D016403","descriptor_name":"Lymphoma, Large B-Cell, Diffuse","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D016403","descriptor_name":"Lymphoma, Large B-Cell, Diffuse","qualifier_ui":"Q000532","qualifier_name":"radiotherapy","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018572","descriptor_name":"Disease-Free Survival","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019070","descriptor_name":"Cell Lineage","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D058846","descriptor_name":"Antibodies, Monoclonal, Murine-Derived","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1111/bjh.13766","doi":"https://doi.org/10.1111/bjh.13766","is_oa":false,"landing_page_url":"https://doi.org/10.1111/bjh.13766","pdf_url":null,"source":{"id":"https://openalex.org/S153015021","display_name":"British Journal of Haematology","issn_l":"0007-1048","issn":["0007-1048","1365-2141"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Haematology","raw_type":"journal-article"},{"id":"pmid:26456939","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/26456939","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British journal of haematology","raw_type":"Comparative Study"},{"id":"pmh:oai:pubmedcentral.nih.gov:4715539","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC4715539/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Br J Haematol","raw_type":"Text"}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:4715539","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC4715539/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Br J Haematol","raw_type":"Text"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.98580002784729}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[{"id":"https://openalex.org/G9000856728","display_name":"Cancer Center Support Grant","funder_award_id":"P30CA008748","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":29,"referenced_works":["https://openalex.org/W1976564639","https://openalex.org/W1982975579","https://openalex.org/W1989377468","https://openalex.org/W2021373870","https://openalex.org/W2038023916","https://openalex.org/W2065157786","https://openalex.org/W2068343048","https://openalex.org/W2068878719","https://openalex.org/W2072351874","https://openalex.org/W2076583917","https://openalex.org/W2086221838","https://openalex.org/W2088751140","https://openalex.org/W2104542331","https://openalex.org/W2108006131","https://openalex.org/W2122863546","https://openalex.org/W2123439935","https://openalex.org/W2142724147","https://openalex.org/W2147246240","https://openalex.org/W2150382709","https://openalex.org/W2158267770","https://openalex.org/W2161205944","https://openalex.org/W2166337528","https://openalex.org/W2313941482","https://openalex.org/W2327610290","https://openalex.org/W2482262707","https://openalex.org/W2554370051","https://openalex.org/W2582743722","https://openalex.org/W2979469687","https://openalex.org/W6769125413"],"related_works":["https://openalex.org/W2529193762","https://openalex.org/W3216431820","https://openalex.org/W172303643","https://openalex.org/W4283377270","https://openalex.org/W7005714747","https://openalex.org/W3030271878","https://openalex.org/W2587826297","https://openalex.org/W2899729636","https://openalex.org/W3135063378","https://openalex.org/W2981160439"],"abstract_inverted_index":{"Therapeutic":[0],"options":[1],"for":[2,134,216],"limited-stage":[3,41,217],"diffuse":[4],"large":[5],"B":[6],"cell":[7],"lymphoma":[8],"(DLBCL)":[9],"include":[10],"short-":[11],"or":[12,45,130],"full-course":[13],"R-CHOP":[14,51,154,162,172,181,238],"(rituximab,":[15],"cyclophosphamide,":[16],"doxorubicin,":[17],"vincristine,":[18],"prednisolone)":[19],"\u00b1":[20,52],"radiotherapy.":[21],"The":[22,27,110,189],"optimal":[23],"treatment":[24,209,221],"remains":[25],"unclear.":[26],"prognostic":[28,231],"value":[29],"of":[30,73,196,201,220],"cell-of-origin":[31],"(COO)":[32],"in":[33,70,126,136,233],"early":[34],"stage":[35,46,80,86,92,98,105],"DLBCL":[36,42],"is":[37],"unknown.":[38],"Patients":[39],"with":[40,50,193,236],"(stage":[43],"I":[44,81],"II,":[47],"non-bulky)":[48],"treated":[49,235],"involved":[53],"field":[54],"radiotherapy":[55],"(IFRT)":[56],"from":[57],"1999":[58],"to":[59],"2012":[60],"were":[61,79,191,204,223],"included.":[62],"COO":[63,226],"by":[64],"the":[65,137,207,212],"Hans":[66],"algorithm":[67],"was":[68,122,227],"analysed":[69],"a":[71,229],"subset":[72],"patients.":[74],"Of":[75],"261":[76],"patients,":[77],"30%":[78],"(N":[82,88,94,100,107],"=":[83,89,95,101,108,143,149],"82),":[84],"37%":[85],"IE":[87],"96),":[90],"<1%":[91],"IXEE":[93],"1),":[96],"18%":[97],"II":[99],"46)":[102],"and":[103,145,178,198,203],"14%":[104],"IIE":[106],"37).":[109],"stage-modified":[111],"International":[112],"Prognostic":[113],"Index":[114],"stratified":[115],"patients":[116,135,152,234],"into":[117],"prognostically":[118],"relevant":[119],"groups.":[120,210],"There":[121],"no":[123],"significant":[124,230],"difference":[125],"progression-free":[127],"survival":[128,132],"(PFS)":[129],"overall":[131],"(OS)":[133],"germinal":[138],"centre":[139],"B-cell-like":[140],"(GCB;":[141],"n":[142],"65)":[144],"non-GCB":[146],"cohorts":[147],"(n":[148],"22).":[150],"Seventeen":[151],"received":[153,161,171,180],"\u00d7":[155,163,173,182],"3-4":[156,164],"cycles":[157,165,175,184],"(Arm":[158,168,176,187],"A),":[159],"147":[160],"+":[166,185,239],"IFRT":[167,186],"B),":[169],"48":[170],"6":[174,183],"C),":[177],"50":[179],"D).":[188],"outcomes":[190,215],"excellent,":[192],"5-year":[194,199],"PFS":[195],"82%":[197],"OS":[200],"93%,":[202],"similar":[205],"across":[206],"4":[208],"In":[211],"rituximab":[213],"era,":[214],"DLBCL,":[218],"regardless":[219],"approach,":[222],"excellent.":[224],"Baseline":[225],"not":[228],"factor":[232],"short-course":[237],"IFRT.":[240]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1898697707","counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":5},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":8},{"year":2020,"cited_by_count":9},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":2}],"updated_date":"2026-11-15T12:55:33.944570","created_date":"2016-06-24T00:00:00"}
